FTC Sues Drug ‘Gatekeepers’ Over High Insulin Prices

The U.S. Federal Trade Commission sued the country’s three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies. The case accuses…[#item_full_content]